JPRN-UMIN000018268
Recruiting
N/A
Clinical investigation of change of bone-related marker between denosumab and zoledronic acid in patients with treatment-naive,bone-metastasis prostate cancer:prospective, multiinstitutional,cohort study - Comparative study between denosumab and zoledronic acid in terms of bone marker
Department of Renal and Urologic Surgery, Asahikawa Medical University0 sites50 target enrollmentDecember 1, 2015
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- treatment-naive prostate cancer with bone metastasis
- Sponsor
- Department of Renal and Urologic Surgery, Asahikawa Medical University
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •history of radiation therapy to bone metastasis, history of dental treatment within 6 weeks of entry,Grade 4 renal insuffuciency such as eGFR under 30 or serum creatinine over 3
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Analyses of factors involved in bone remodeling and inflammation in Ankylosing Spondylitis (AS) patients undergoing etanercept therapyM45.00DRKS00004838Rheumazentrum Prof. Dr. med. G. Neeck56
Recruiting
N/A
Analysis of physiological markers, physical fitness, self-esteem and self-image in elderly people undergoing adapted TaekwondoRBR-5jzcc5qniversidade Estácio de Sá
Active, Not Recruiting
Phase 1
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody.An investigator-led, industry supported, multicentre, open-label, single treatment arm, prospective clinical trial. - Effects of B cell depletion on bone turnover in rheumatoid arthritis.EUCTR2010-020499-50-GBSouth Tees Hospitals NHS Foundation Trust46
Completed
N/A
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting antibodyISRCTN82317088South Tees Hospitals NHS Foundation Trust (UK)46
Active, Not Recruiting
Phase 2
Evaluation of soft tissue and crestal bone changes around non submerged platform switch implants placed epicrestal and subcrestalHealth Condition 1: K069- Disorder of gingiva and edentulousalveolar ridge, unspecifiedCTRI/2021/07/034797chennu swetha28